Work

Significant association between lncRNA H19 polymorphisms and cancer susceptibility: a meta-analysis

Year: 2017
Type: review
Abstract: // Xue-Feng Li 1, * , Xin-Hai Yin 2, * , Jun-Wei Cai 1, * , Ming-Ju Wang 3 , Yu-Qin Zeng 1 , Min Li 1 , Yu-Ming Niu 1, 4 and Ming Shen 5 1 Department of Endocrinology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China 2 Department of Oral and Maxillary Surgery, Gui Zhou Provincial People’s Hospital, Guiyang 550000, China 3 Information Resources, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China 4 Department of Stomatology and Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China 5 Jiangsu Key Laboratory of Oral Diseases, Department of Dental Implant, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing 210029, China * These authors contributed equally to this work Correspondence to: Yu-Ming Niu, email: [email protected] Ming Shen, email: [email protected] Keywords: H19, polymorphism, cancer, meta-analysis Received: August 15, 2016 Accepted: March 19, 2017 Published: March 29, 2017 ABSTRACT Previous epidemiological research suggests polymorphisms in long non-coding RNA (lncRNA) H19 are associated with an increased risk of cancer, but the results are inconsistent. We therefore conducted a meta-analysis to more accurately determine the association between lncRNA H19 polymorphisms and cancer risk. The PubMed, Embase, and Science Citation Index online databases were searched and 11 relevant studies involving a total of 33,209 participants were identified. Odds ratios (ORs) and corresponding 95% confidence interval (CIs) from these studies were used to detect associations between H19 polymorphisms and cancer risk using five genetic models. The pooled result suggested that the rs2839698 G>A polymorphism was associated with digestive cancer risk in all five models. Moreover, a protective effect against cancer development was observed for the T allele variant of the rs2107425 C>T polymorphism, especially in Caucasian patient populations. No significant associations were found between lncRNA H19 rs217727 G>A polymorphism and cancer risk. In summary, the rs2839698 G>A and rs2107425 C>T polymorphisms in lncRNA H19 may therefore play opposing roles during cancer development, and their effects may vary depending on cancer type and patient ethnicity.
Source: Oncotarget
Language: English
Subfield: Cancer Research
Open Access status: diamond
OpenAlex ID: W2603390197
FWCI: 0.647
Cites: 47
Cited by: 33
Related to: 9